Preparation and characterization of negatively charged poly(lactic-co- glycolic acid) microspheres

Journal of Pharmaceutical Sciences

Volumn 98, Issue 7, 2009, Pages 2377-2389

  Xu, Qingguo ^a   Crossley, Alison ^a   Czernuszka, Jan ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Anionic surfactants; Controlled release; Microencapsulation; Microspheres; Negative surface charge; PLGA; Solid in oil in water

Indexed keywords

AMOXICILLIN; DOCUSATE SODIUM; DODECYL SULFATE SODIUM; MICROSPHERE; POLYGLACTIN; POLYVINYL ALCOHOL;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DIFFUSION; DRUG DEGRADATION; ENCAPSULATION; EVAPORATION; HYDROPHILICITY; IN VITRO STUDY; PARTICLE SIZE; SUSTAINED DRUG RELEASE; SYNTHESIS;

EID: 67650115442     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.21612     Document Type: Article

References (43)

1. Yamaguchi K, Anderson JM. 1993. In vivo biocompatibility studies of Medisorb® 65/35 D, L-lactide glycolide copolymer microspheres. J Control Release 24:81-93.
2. Langer R, Folkman J. 1976. Polymers for sustained release of proteins and other macromolecules. Nature 263:797-800.
3. Mu L, Feng SS. 2003. A novel controlled release formulation for the anticancer drug paclitaxel (Taxol (R)): PLGA nanoparticles containing vitamin E TPGS. J Control Release 86:33-48. (Pubitemid 35469120)
4. Park TG, Lu WQ, Crotts G. 1995. Importance of in-vitro experimental conditions on protein release kinetics, stability and polymer degradation in protein encapsulated poly(D,L-lactic acid-co-glycolic acid) microspheres. J Control Release 33:211-222.
5. Johnson RE, Lanaski LA, Gupta V, Griffin MJ, Gaud HT, Needham TE, Zia H. 1991. Stability of atriopeptin-III in poly(D,L-lactide-co-glycolide) microspheres. J Control Release 17:61-67.
6. Ibrahim MA, Ismail A, Fetouh MI, Gopferich A. 2005. Stability of insulin during the erosion of poly(lactic acid) and poly(lactic-co-glycolic acid) microspheres. J Control Release 106:241-252. (Pubitemid 41187434)
7. Schnieders J, Gbureck U, Thull R, Kissel T. 2006. Controlled release of gentamicin from calcium phosphate - Poly(lactic acid-co-glycolic acid) composite bone cement. Biomaterials 27:4239-4249. (Pubitemid 44294361)
8. Prior S, Gamazo C, Irache JM, Merkle HP, Gander B. 2000. Gentamicin encapsulation in PLA/PLGA microspheres in view of treating Brucella infections. Int J Pharm 196:115-125. (Pubitemid 30089520)
9. Prior S, Gander B, Irache JM, Gamazo C. 2005. Gentamicin-loaded microspheres for treatment of experimental Brucella abortus infection in mice. J Antimicrob Chemother 55:1032-1036. (Pubitemid 40883195)
10. Jilek S, Merkle HP, Walter E. 2005. DNA-loaded biodegradable microparticles as vaccine delivery systems and their interaction with dendritic cells. Adv Drug Deliv Rev 57:377-390. (Pubitemid 39550966)
11. Tamber H, Johansen P, Merkle HP, Gander B. 2005. Formulation aspects of biodegradable polymeric microspheres for antigen delivery. Adv Drug Deliv Rev 57:357-376. (Pubitemid 39555502)
12. Sinha VR, Trehan A. 2003. Biodegradable microspheres for protein delivery. J Control Release 90: 261-280.
13. van de Weert M, Hennink WE, Jiskoot W. 2000. Protein instability in poly(lactic-co-glycolic acid) microparticles. Pharm Res 17:1159-1167.
14. Singh M, Kazzaz J, Ugozzoli M, Chesko J, O'Hagan DT. 2004. Charged polylactide co-glycolide microparticles as antigen delivery systems. Expert Opin Biol Ther 4:483-491. (Pubitemid 38480548)
15. Kazzaz J, Neidleman J, Singh M, Ott G, O'Hagan DT. 2000. Novel anionic microparticles are a potent adjuvant for the induction of cytotoxic T lymphocytes against recombinant p55 gag from HIV-1. J Control Release 67:347-356. (Pubitemid 30303847)
16. Singh M, Kazzaz J, Chesko J, Soenawan E, Ugozzoli M, Giuliani M, Pizza M, Rappouli R, O'Hagan DT. 2004. Anionic microparticles are a potent delivery system for recombinant antigens from Neisseria meningitidis serotype B. J Pharm Sci 93:273-282. (Pubitemid 38174250)
17. Singh M, Chesko J, Kazzaz J, Ugozzoli M, Kan E, Srivastava I, O'Hagan DT. 2004. Adsorption of a novel recombinant glycoprotein from HIV (Env gp120dV2 SF162) to anionic PLG microparticles retains the structural integrity of the protein, whereas encapsulation in PLG microparticles does not. Pharm Res 21:2148-2152. (Pubitemid 40568427)
18. Keegan ME, Falcone JL, Leung TC, Saltzman WM. 2004. Biodegradable microspheres with enhanced capacity for covalently bound surface ligands. Macromolecules 37:9779-9784. (Pubitemid 40079964)
19. Caponetti G, Hrkach JS, Kriwet B, Poh M, Lotan N, Colombo P, Langer R. 1999. Microparticles of novel branched copolymers of lactic acid and amino acids: Preparation and characterization. J Pharm Sci 88: 136-141. (Pubitemid 29037381)
20. Eniola AO, Hammer DA. 2005. Characterization of biodegradable drug delivery vehicles with the adhesive properties of leukocytes - II: Effect of degradation on targeting activity. Biomaterials 26:661-670. (Pubitemid 38988308)
21. Eniola AO, Rodgers SD, Hammer DA. 2002. Characterization of biodegradable drug delivery vehicles with the adhesive properties of leukocytes. Biomaterials 23:2167-2177. (Pubitemid 34226577)
22. Eniola AO, Hammer DA. 2003. Artificial polymeric cells for targeted drug delivery. J Control Release 87:15-22. (Pubitemid 36255444)
23. Murphy WL, Mooney DJ. 2002. Bioinspired growth of crystalline carbonate apatite on biodegradable polymer substrata. J Am Chem Soc 124:1910-1917. (Pubitemid 34215307)
24. Zhang RY, Ma PX. 1999. Porous poly(L-lactic acid)/ apatite composites created by biomimetic process. J Biomed Mater Res 45:285-293. (Pubitemid 29196674)
25. Wang YQ, Qu X, Lu J, Zhu CF, Wan LJ, Yang JL, Bei JZ, Wang SG. 2004. Characterization of surface property of poly(lactide-co-glycolide) after oxygen plasma treatment. Biomaterials 25:4777-4783. (Pubitemid 38561165)
26. McCarron PA, Donnelly RF, Canning PE, McGovern JG, Jones DS. 2004. Bioadhesive, non-drugloaded nanoparticles as modulators of candidal adherence to buccal epithelial cells: A potentially novel prophylaxis for candidosis. Biomaterials 25:2399-2407. (Pubitemid 38102393)
27. Fahmy TM, Samstein RM, Harness CC, Saltzman WM. 2005. Surface modification of biodegradable polyesters with fatty acid conjugates for improved drug targeting. Biomaterials 26:5727-5736. (Pubitemid 40616843)
28. Takada S, Kurokawa T, Miyazaki K, Iwasa S, Ogawa Y. 1997. Utilization of an amorphous form of a water-soluble GPIIb/IIIa antagonist for controlled release from biodegradable microspheres. Pharm Res 14:1146-1150. (Pubitemid 27432535)
29. Cleland JL, Jones AJS. 1996. Stable formulations of recombinant human growth hormone and interferon- gamma for microencapsulation in biodegradable microspheres. Pharm Res 13:1464-1475. (Pubitemid 26356947)
30. Lamprecht A, Torres HR, Schafer U, Lehr CM. 2000. Biodegradable microparticles as a two-drug controlled release formulation: A potential treatment of inflammatory bowel disease. J Control Release 69:445-454. (Pubitemid 30845488)
31. Castellanos IJ, Flores G, Griebenow K. 2006. Effect of cyclodextrins on alpha-chymotrypsin stability and loading in PLGA microspheres upon S/O/W encapsulation. J Pharm Sci 95:849-858.
32. Toorisaka E, Ono H, Arimori K, Kamiya N, Goto M. 2003. Hypoglycemic effect of surfactant-coated insulin solubilized in a novel solid-in-oil-inwater (S/O/W) emulsion. Int J Pharm 252:271-274. (Pubitemid 36126637)
33. Schramm LL. 2005. Emulsions, foams, and suspensions: Fundamentals and applications. Weinheim: Wiley-VCH.
34. Myers D. 2005. Surfactant science and technology. 3rd edition. Weinheim: Wiley.
35. Bouissou C, Potter U, Altroff H, Mardon H, van der Walle C. 2004. Controlled release of the fibronectin central cell binding domain from polymeric microspheres. J Control Release 95:557-566. (Pubitemid 38340505)
36. Jameela SR, Suma N, Jayakrishnan A. 1997. Protein release from poly(epsilon-caprolactone) microspheres prepared by melt encapsulation and solvent evaporation techniques: A comparative study. J Biomater Sci Polym Ed 8:457-466. (Pubitemid 27196922)
37. Boury F, Marchais H, Proust JE, Benoit JP. 1997. Bovine serum albumin release from poly(alphahydroxy acid) microspheres: Effects of polymer molecular weight and surface properties. J Control Release 45:75-86. (Pubitemid 27055795)
38. Morita T, Sakamura Y, Horikiri Y, Suzuki T, Yoshino H. 2000. Protein encapsulation into biodegradable microspheres by a novel S/O/W emulsion method using poly(ethylene glycol) as a protein micronization adjuvant. J Control Release 69: 435-444. (Pubitemid 30845487)
39. Mu L, Feng SS. 2002. Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol (R)). J Control Release 80:129-144. (Pubitemid 34273754)
40. Xu Q, Czernuszka JT. 2008. Controlled release of amoxicillin from hydroxyapatite-coated poly(lacticco- glycolic acid) microspheres. J Control Release 127:146-153.
41. Siepmann J, Faisant N, Benoit JP. 2002. A new mathematical model quantifying drug release from bioerodible microparticles using Monte Carlo simulations. Pharm Res 19:1885-1893. (Pubitemid 36016038)
42. Schlicher E, Postma NS, Zuidema J, Talsma H, Hennink WE. 1997. Preparation and characterisation of poly(D,L-lactic-co-glycolic acid) microspheres containing desferrioxamine. Int J Pharm 153:235-245. (Pubitemid 27308667)
43. Ha JH, Kim SH, Han SY, Sung YK, Lee YM, Kang IK, Cho CS. 1997. Albumin release from bioerodible hydrogels based on semi-interpenetrating polymer networks composed of poly(epsilon-caprolactone) and poly(ethylene glycol) macromer. J Control Release 49:253-262. (Pubitemid 28020278)